Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy

Applied and Environmental Microbiology

Volumn 64, Issue 7, 1998, Pages 2335-2340

  Chen, Ping ^a   Novak, Jan ^a   Kirk, Marion ^a   Barnes, Stephen ^b,c   Qi, Fengxia ^a   Caufield, Page W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANTIBIOTIC; MUTACIN 2; SERINE; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DNA SEQUENCE; DRUG ACTIVITY; DRUG ISOLATION; DRUG SYNTHESIS; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; NONHUMAN; PEPTIDE SYNTHESIS; SITE DIRECTED MUTAGENESIS; STREPTOCOCCUS MUTANS; STRUCTURE ACTIVITY RELATION; TANDEM MASS SPECTROMETRY;

POSIBACTERIA; STREPTOCOCCUS MUTANS;

EID: 0031842742     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.7.2335-2340.1998     Document Type: Article

References (30)

1. Bierbaum, G., M. Reis, C. Szekat, and H.-G. Sahl. 1994. Construction of an expression system for engineering of the lantibiotic Pep 5. Appl. Environ. Microbiol. 60:4332-4338.
2. Bierbaum, G., C. Szekat, M. Josten, C. Heidrich, C. Kempter, G. Jung, and H.-G. Sahl. 1996. Engineering of a novel thiether bridge and role of modified residues in the lantibiotic Pep 5. Appl. Environ. Microbiol. 62:385-392.
3. Caufield, P. W., N. K. Childers, D. N. Allen, and J. B. Hansen. 1985. Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect. Immun. 48:51-56.
4. Caufield, P. W., G. R. Shah, and S. K. Hollingshead. 1990. Use of transposon Tn916 to inactivate and isolate a mutacin-associated gene from Streptococcus mutans. Infect. Immun. 58:4126-4135.
5. Chan, W. C., B. W. Bycroft, L.-Y. Lian, and G. C. K. Roberts. 1989. Isolation and characterization of two degradation products derived from the peptide antibiotic nisin. FEBS Lett. 252:29-36.
6. Chan, W. C., H. M. Dodd, N. Horn, K. Maclean, L.-Y. Lian, B. W. Bycroft, M. J. Gasson, and G. C. K. Roberts. 1996. Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine. Appl. Environ. Microbiol. 62:2966-2969.
7. Chikindas, M. L., J. Novak, A. J. M. Driessen, W. N. Konings, K. M. Schilling, and P. W. Caufield. 1995. Mutacin II, a bactericidal lantibiotic from Streptococcus mutans. Antimicrob. Agents Chemother. 39:2656-2660.
8. Dodd, H. M., N. Horn, C. J. Giffard, and M. J. Gasson. 1996. A gene replacement strategy for engineering nisin. Microbiology 142:47-55.
9. Flannagan, S. E., L. A. Zitzow, Y. A. Su, and D. B. Clewell. 1994. Nucleotide sequence of the 18-kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid 32:350-354.
10. Jung, G. 1991. Lantibiotics: a survey, p. 1-34. In G. Jung and H. G. Sahl (ed.), Nisin and novel lantibiotics. ESCOM Science Publishers, Leiden, The Netherlands.
11. Kuipers, O. P., G. Bierbaum, B. Ottenwalder, H. M. Dodd, N. Horn, J. Metzger, T. Kupke, V. Gnau, R. Bongers, P. van den Bogaard, H. Kosters, H. S. Rollema, W. M. de Vos, R. J. Siezen, G. Jung, F. Götz, H. G. Sahl, and M. J. Gasson. 1996. Protein engineering of lantibiotics. Antonie Leeuwenhoek 69:161-170.
12. Kuipers, O. P., H. S. Rollema, W. M. G. J. Yap, H. J. Boot, R. J. Siezen, and W. M. de Vos. 1992. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267:24340-24346.
13. Li, Y. Unpublished data.
14. Liu, W., and J. N. Hansen. 1993. The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms. Appl. Environ. Microbiol. 59:648-651.
15. Liu, W., and J. N. Hansen. 1992. Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. J. Biol. Chem. 267:25078-25085.
16. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
17. Novak, J., P. W. Caufield, and E. J. Miller. 1994. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J. Bacteriol. 176:4316-4320.
18. Novak, J., P. Chen, M. Kirk, S. Barnes, M. J. Jablonsky, S. K. Holaday, N. R. Krishna, J. Baker, and P. W. Caufield. 1997. Structure and activity of the lantibiotic mutacin II. Evidence for two domains? Nat. Biotechnol. Short Rep. 8:87.
19. Novak, J., M. Kirk, P. W. Caufield, S. Barnes, K. Morrison, and J. Baker. 1996. Detection of modified amino acids in lantibiotic peptide mutacin II by chemical derivatization followed by electrospray ionization mass spectroscopic analysis. Anal. Biochem. 236:358-360.
20. Novak, J., L. Novak, G. R. Shah, W. Woodruff, and P. W. Caufield. 1997. Transposon mutagenesis: cloning of chromosomal DNA from the site of Tn916 insertion using polymerase chain reaction. Biotechnol. Tech. 11:51-54.
21. Ottenwalder, B., T. Kupke, T. Brecht, V. Gnau, J. Metzger, G. Jung, and F. Götz. 1995. Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl. Environ. Microbiol. 61:3894-3903.
22. Parrot, M., P. W. Caufield, and M. C. Lavoie. 1990. Preliminary characterization of four bacteriocins from Streptococcus mutans. Can. J. Microbiol. 36:123-130.
23. Sahl, H.-G., R. W. Jack, and G. Bierbaum. 1995. Lantibiotics: biosynthesis and biological activities of peptides with unique post-translational modifications. Eur. J. Biochem. 230:827-853.
24. Schnell, N., K.-D. Entian, U. Schneider, F. Götz, H. Zähner, R. Kellner, and G. Jung. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulfide-rings. Nature 333:276-278.
25. Shah, G. R., and P. W. Caufield. 1993. Enhanced transformation of Streptococcus mutans by modifications in culture conditions. Anal. Biochem. 214: 343-346.
26. Shyamala, V., and G. F.-L. Ames. 1993. Genome walking by single specific primer-polymerase chain reaction. Methods Enzymol. 217:436-446.
27. Trieu-Cuot, P., and P. Courvalin. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′5″-amino glycoside phosphotransferase type III. Gene 23:331-341.
28. Walsh, P. S., D. A. Metzger, and R. Higuchi. 1991. Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 10:506-513.
29. Woodruff, W. A., J. Novak, and P. W. Caufield. 1998. Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans. Gene 206:37-43.
30. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.